What Lamark Biotech does
Founded in 2018, Lamark Biotech operates in Health Tech offering innovative molecular medicines to support sustainable and affordable healthcare systems globally. The company focuses on developing therapeutic proteins, gene therapies, and cell therapies, which have advanced significantly in recent years but remain unaffordable for most patients. Lamark aims to enhance accessibility and affordability of these medicines by redesigning existing solutions and promoting sustainable business strategies. Its mission is to ensure that the benefits of molecular medicine are available to all individuals in need.
Who runs it
Funding and finances
Why this matters to you: funding stage is a rough proxy for how long the runway is and how much structure to expect. It is not a promise, and a profitable bootstrapped company can be the safer bet.
Check the company’s own careers page — linked at the top — before a job board. A role appears there first, sometimes weeks before it is syndicated anywhere else.
Questions and experiences
Nobody has asked anything about Lamark Biotech yet. If you have interviewed here, what you know is worth more to the next person than anything on the rest of this page.
Company facts compiled from public sources and last refreshed 9 September 2026. Details change; treat the company’s own site as the authority.